一种选择性的S-转移酶抑制剂抑制了瘤生长
bioRxiv : the preprint server for biology
|August 2, 2024
概括
研究人员确定了一种新型抑制剂SD-066-4,向ZDHHC20以阻止肺瘤生长. 这种S-化抑制剂在治疗克拉斯突变肺癌和改善患者存活率方面表现有前途.
科学领域:
- 生物化学和分子生物学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- S-乙转移酶对于生理过程至关重要,包括瘤信号传递.
- 缺乏特定的S-化抑制剂阻碍了疾病的治疗发展.
- 准S-转移酶为人类疾病提供了潜在的好处,但仍然在很大程度上未被探索.
研究的目的:
- 确定和描述一种新的,口服生物可利用的S-转移酶抑制剂.
- 为了研究抑制ZDHHC20在克拉斯突变肺癌中的治疗潜力.
- 探索ZDHHC20和ZDHHC14在肺癌患者结局中的临床相关性.
主要方法:
- 一种口服生物可用的乙转移酶抑制剂的鉴定,SD-066-4.4.
- 通过氨酸残留相互作用来表征SD-066-4的异型选择性.
- 评估SD-066-4对Kras突变细胞中EGFR S-化作用.
- 在临床前模型中评估SD-066-4在阻断克拉斯突变肺瘤生长和生存方面的疗效.
- 对肺癌患者数据进行分析,分析ZDHHC20/ZDHHC14删除,Kras变化和生存益处之间的相关性.
主要成果:
- SD-066-4被确定为一种口服生物可利用的乙转移酶ZDHHC20.20的抑制剂.
- 发现一种特定的氨酸残留物赋予SD-066-4.4的异型选择性.
- SD-066-4有效地降低了Kras突变细胞中的EGFR S-化.
- 该抑制剂阻断了克拉斯突变肺瘤的生长,并延长了整体生存期.
- 患有ZDHHC20/ZDHHC14删除和Kras改变的肺癌患者显示出显著的生存益处.
结论:
- SD-066-4是一种强效和选择性的ZDHHC20抑制剂,已证明对克拉斯突变肺瘤的有效性.
- 药理上抑制ZDHHC20代表了克拉斯突变肺癌的一个有前途的治疗策略.
- 这些发现凸显了ZDHHC20和ZDHHC14在肺癌治疗和患者分层中的转化重要性.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


